This will explain information about an article written by Dr. David Samadi about former presidential candidate for the Republican party Mitt Romney. Later, general information will be given about Dr. David Samadi. Recently, Romney had given an announcement that last summer he went under prostate surgery. This cancer occurs mainly in those who had a diagnosis in prostate cancer. This was from a tumor that was slow growing that he got diagnosed with earlier. Recently, Romney has disclosed his health history of the past. The good news is this might be a sign that he could potentially run in Utah for the U.S Senate seat. This will be vacated on by Orrin Hatch.
The surgery that ended well happened in California at the UC Irvine Hospital. He had a good prognosis as he joined a total of 161,360 other men in 2017 who had the diagnosis of prostate cancer. Romney along with other familiar faces like John Kerry and Colin Powell had chosen surgery for their Prostate cancer. It is really vital for men with prostate cancer to look for an experienced and qualified oncologist or urologist. This is to help them on the journey. Really good news is that they have succeeded when they were diagnosed with prostate cancer. It is hoped for a longer life ahead and good health. This will help in making choices that are informed and educated as well. This will serve as the best cure for helping in beating back prostate cancer.
Now, some general information about Dr. David Samadi. Dr. Samadi currently works in Lenox Hill Hospital as the “Chairman of Urology and Chief of Robotic Surgery.” The hospital is located in New York, New York. He has held onto his positon since 2012. This Dr. spent his high school years in different schools across a variety of countries. For example, the countries of Belgium, the U.S, and London. He currently went back to the United States and made it his current home. In college, he received a degree in biochemistry from Stony Brook University. He recently received a scholarship in full from the school. This would help him unlock his dream of becoming a medical doctor. His main specialty is in urology in treating different cancers. The different cancers he cured were bladder, kidney, and prostate.
To know more visit @ www.facebook.com/DrDavidSamadi/
About Jason Hope
Jason Hope is an Arizona-based healthcare technology investor, entrepreneur, and philanthropist. As a futurist, Hope sheds light on issues related to entrepreneurship and technology. He ventured into the business world shortly after graduating with a bachelor’s degree in Finance from Arizona State University. At first, mobile communication technology inspired Jason Hope due to its benefits and broad outreach. For him, it’s merely the best catalyst for change. While no longer new, Jason Hope believes that mobile communication technology still has room for growth and development. Selling premium text message services prepared Jason Hope for his future as a futurist and healthcare technology investor.
Jason Hope would earn a living from his diverse portfolio of technology companies. He began by creating a mobile communication company, Jawa, which would act as a parent company for his subsidiaries. His collection of corporations includes Interactive Software, Digital Media Solutions, and Marketing Services. Jason Hope believes that the future of society is technology dependent. The impetus behind the creation of Jawa was that technology connects things, regions, and people all over the world. As a tech entrepreneur, you always have to keep current with tech trends. Fortunately, Jason Hope’s first venture was profitable, and that encouraged him to build his portfolio by investing in other companies and individuals, and resume him.
Jason Hope encourages entrepreneurs always remain positive. That’s what keeps them on toes and focused on improving their bottom line. Any new concept or project you undertake will undoubtedly present challenges. However, what makes an entrepreneur successful is how they manage operational problems and handle failure. While Hope could sometimes be doubtful, he would use that doubt to fuel his passion for change. Jason Hope has always been drawn to the world of technology and knew that his career would be in line with technology. His belief in the power of technology is enough for him to soldier on and overcome his doubts.
This Chinese city plans to track all cars electronically #IoT https://t.co/jeDCHKWKAz
— Jason Hope (@JasonHope) March 15, 2016
Jason Hope got his first referral through rigorous awareness campaigns. He invests heavily in social media as his marketing platform. For him, social media is a tested method that never fails to generate new business connections. For example, Twitter is an effective channel to share ideas, capitalize on new opportunities, and stay on top of potential customer’s mind. Jason Hope attributes his success to his ability to navigate tech trends and the potential it has in improving businesses, and https://gust.com/companies/jason-hope.
When he started Groupon, Eric Lefkofsky aimed at saving money for his customers and helping them to travel across the globe but eventually made a fortune from the company. He subsequently opened a new startup known as Tempus which is aimed at helping people better their health. The organization uses genomic sequencing to help physicians offer better treatment to cancer patients. Tempus has been organizing for series of fundraising and has been able to raise about $70 million from New Enterprise Associates and Revolution growth. The amount of money constitutes the $130 million that Tempus has raised since Eric Lefkofsky first co-founded it barely two years ago. He co-founded it together with his friend and business partner.
Speculations have it that Tempus is valued at about $700 million. For every fundraising round that has been conducted in support of Tempus and its course, Eric Lefkofsky and his co-founder have been investing as individuals. They are indeed the largest investors of the institution. In an interview conducted by Crain’s Chicago Business, Eric Lefkofsky revealed that he would invest up to a total of $100 million in the business. Tempus is not the first company that New Investors Associates and Revolution growth are funding. They have previously supported a revolutionary food chain Known as Sweetgreens, a genome organization known as 23AandMe, as well as a trading app known as Robinhood.
About three years ago, one of the close relatives of Eric Lefkofsky was diagnosed with cancer. During the treatment process, he observed that there lacked an up to date way of collecting data. It is this situation that motivated him to start up Tempus. Tempus has now made it possible to bring together large quantities of clinical data from cancer patients to help physicians offer better personalizes treatment.
Eric Lefkofsky was born in the year 1969 to a structural engineer. He attended the University of Michigan. Later, he earned his Juris Doctor from University of Michigan School of law. At one time, Mr. Lefkofsky was selling carpets at the University of Michigan. Even after starting up Tempus, he remained the chief executive of Groupon.
Foresite Capital has had a busy beginning to their 2017 year. The medical research growth equity firm has been bringing on high profile, big name talent to their team. New addition Jim Tananbaum, M.D, was named to the Forbe’s Midas List of Top Tech Investors for an incredible third straight time. On the heels of his successful month the company decided to add another venture partner to the team, Dr. Molly He. News of Dr. He’s addition to the team was welcomed and immediately receptive from high ranking members of Foresite Capital.
The first person to welcome Dr. He to the team was Dr. Jim Tananbaum himself. Dr. Tananbaum spoke in a statement regarding Dr. He where he regarded her as one of the most respected of scientific researchers in the field of next generation sequencing. Dr. Tananbaum regaled her experience in the field of genomics as well as drug development and considered her also a remarkable leader with an extensive track record as both a leader and a team member. He finished off his statement by calling her ‘an invaluable resource to Foresite’ as they ‘continue to expand and diversify our portfolio of transformational companies.’
According to Fierce Biotech, Dr. Tananbaum’s words are more than just fluff to welcome a new employee. Dr. Tananbaum himself established Foresite Capital and he has a total of 25 years’ worth of leadership within the industry. Tananbaum’s been an active investor in the healthcare field while focusing on the different ways you can build and develop franchise healthcare businesses. Dr. Jim Tananbaum also helped to co-found GelTex Pharmaceuticals which managed to bring two different drugs to the market before being bought out for a jaw dropping $1.6 billion.
Of course, Dr. He would not be invited to the team without her own skills evidenced and on display. Dr. He previously worked as the senior director of scientific research over at Illumina where she served the company for years. Before Illumina Dr. He had spent ten years in the pharmaceutical industry as well as in a leadership role over at Pacific Biosciences. Needless to say, Dr. He will be welcomed with open arms at Foresite Capital. More details can be found on LinkedIn.
Read more: https://www.researchgate.net/profile/Jim_Tananbaum